These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24290927)

  • 41. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
    Ledzewicz U; Schättler H
    Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Two elderly patients with advanced gastric cancer responding to chronomodulation chemotherapy with tegafur + cisplatin + isovorin followed by oral administration of S-1].
    Kobayashi A; Yamaguchi M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):1003-7. PubMed ID: 11478129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Support-based distributed optimisation: an approach to radiotherapy patient scheduling.
    Billiau G; Chang CF; Miller A; Ghose A
    Stud Health Technol Inform; 2010; 159():229-33. PubMed ID: 20543441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimal chemotherapy regimens: influence of tumours on normal cells and several toxicity constraints.
    Matveev AS; Savkin AV
    IMA J Math Appl Med Biol; 2001 Mar; 18(1):25-40. PubMed ID: 11339336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Curative and palliative aspects of regional chemotherapy in combination with surgery.
    Müller H; Hilger R
    Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiangiogenic scheduling of lower dose cancer chemotherapy.
    Gately S; Kerbel R
    Cancer J; 2001; 7(5):427-36. PubMed ID: 11693902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics.
    Gaffney EA
    Bull Math Biol; 2005 May; 67(3):563-611. PubMed ID: 15820743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling multi-drug chemotherapy: tailoring treatment to individuals.
    Gardner SN
    J Theor Biol; 2002 Jan; 214(2):181-207. PubMed ID: 11812172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Model for tumour growth with treatment by continuous and pulsed chemotherapy.
    Borges FS; Iarosz KC; Ren HP; Batista AM; Baptista MS; Viana RL; Lopes SR; Grebogi C
    Biosystems; 2014 Feb; 116():43-8. PubMed ID: 24333154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of heterogeneity on optimal regimens in cancer chemotherapy.
    Murray JM; Coldman AJ
    Math Biosci; 2003 Sep; 185(1):73-87. PubMed ID: 12900142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multi-objective optimal chemotherapy control model for cancer treatment.
    Algoul S; Alam MS; Hossain MA; Majumder MA
    Med Biol Eng Comput; 2011 Jan; 49(1):51-65. PubMed ID: 20886373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical pathways scheduling using hybrid genetic algorithm.
    Du G; Jiang Z; Yao Y; Diao X
    J Med Syst; 2013 Jun; 37(3):9945. PubMed ID: 23576080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Multiconstrained Grid Scheduling Algorithm with Load Balancing and Fault Tolerance.
    Keerthika P; Suresh P
    ScientificWorldJournal; 2015; 2015():349576. PubMed ID: 26161438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic algorithm based system for patient scheduling in highly constrained situations.
    Podgorelec V; Kokol P
    J Med Syst; 1997 Dec; 21(6):417-27. PubMed ID: 9555628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlling infectious disease outbreaks: A deterministic allocation-scheduling model with multiple discrete resources.
    Rachaniotis N; Dasaklis TK; Pappis C
    J Syst Sci Syst Eng; 2017; 26(2):219-239. PubMed ID: 32288410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle.
    Murray JM
    Math Biosci; 1994 Oct; 123(2):183-213. PubMed ID: 7827419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A mathematical model of cancer chemotherapy with an optimal selection of parameters.
    Martin RB; Fisher ME; Minchin RF; Teo KL
    Math Biosci; 1990 May; 99(2):205-30. PubMed ID: 2134520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple model predictive control for optimal drug administration of mixed immunotherapy and chemotherapy of tumours.
    Sharifi N; Ozgoli S; Ramezani A
    Comput Methods Programs Biomed; 2017 Jun; 144():13-19. PubMed ID: 28494997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Importance of chemotherapy scheduling: pieces of the puzzle.
    Hryniuk W
    Cancer Invest; 1999; 17(7):545-6. PubMed ID: 10518199
    [No Abstract]   [Full Text] [Related]  

  • 60. Cell cycle phase-specific chemotherapy: computational methods for guiding treatment.
    Gardner SN
    Cell Cycle; 2002; 1(6):369-74. PubMed ID: 12548007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.